https://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 11:36:00 +0200Wed, 13 Mar 2024 12:42:00 +0100https://www.ema.europa.eu/en/medicines/human/EPAR/blenrepHuman medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 25/08/2020, Revision: 8, Status: Withdrawn (authorisation)https://www.ema.europa.eu/en/medicines/human/EPAR/blenrepWed, 13 Mar 2024 12:42:00 +0100Human medicinehttps://www.ema.europa.eu/system/files/documents/product-information/blenrep-epar-product-information_en.pdfBlenrep : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/blenrep-epar-product-information_en.pdfWed, 13 Mar 2024 12:24:00 +0100Human medicine